nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—lung cancer	0.541	1	CbGaD
Clobetasol propionate—CYP1A1—Gefitinib—lung cancer	0.128	0.489	CbGbCtD
Clobetasol propionate—CYP1A1—Erlotinib—lung cancer	0.0755	0.289	CbGbCtD
Clobetasol propionate—CYP1A2—Erlotinib—lung cancer	0.0337	0.129	CbGbCtD
Clobetasol propionate—CYP1A2—Etoposide—lung cancer	0.0244	0.0933	CbGbCtD
Clobetasol propionate—Pustule—Erlotinib—lung cancer	0.00802	0.0718	CcSEcCtD
Clobetasol propionate—Rosacea—Erlotinib—lung cancer	0.00497	0.0445	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Erlotinib—lung cancer	0.00318	0.0284	CcSEcCtD
Clobetasol propionate—Eruption—Gefitinib—lung cancer	0.00295	0.0264	CcSEcCtD
Clobetasol propionate—Rash pustular—Gefitinib—lung cancer	0.00228	0.0204	CcSEcCtD
Clobetasol propionate—Tenderness—Gefitinib—lung cancer	0.00208	0.0186	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Erlotinib—lung cancer	0.00182	0.0163	CcSEcCtD
Clobetasol propionate—Folliculitis—Erlotinib—lung cancer	0.00173	0.0155	CcSEcCtD
Clobetasol propionate—Amcinonide—ANXA1—lung cancer	0.00166	0.399	CrCbGaD
Clobetasol propionate—Telangiectasia—Methotrexate—lung cancer	0.00164	0.0146	CcSEcCtD
Clobetasol propionate—Rash pustular—Erlotinib—lung cancer	0.00136	0.0122	CcSEcCtD
Clobetasol propionate—Tenderness—Erlotinib—lung cancer	0.00124	0.0111	CcSEcCtD
Clobetasol propionate—Eruption—Gemcitabine—lung cancer	0.00123	0.011	CcSEcCtD
Clobetasol propionate—Dry skin—Gefitinib—lung cancer	0.00121	0.0108	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—lung cancer	0.00114	0.0102	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Paclitaxel—lung cancer	0.00106	0.0095	CcSEcCtD
Clobetasol propionate—Folliculitis—Paclitaxel—lung cancer	0.001	0.00899	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Crizotinib—lung cancer	0.000999	0.00894	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Crizotinib—lung cancer	0.000989	0.00885	CcSEcCtD
Clobetasol propionate—Leukoderma—Methotrexate—lung cancer	0.000907	0.00812	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Docetaxel—lung cancer	0.0009	0.00805	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Gefitinib—lung cancer	0.000898	0.00804	CcSEcCtD
Clobetasol propionate—Eruption—Docetaxel—lung cancer	0.00087	0.00779	CcSEcCtD
Clobetasol propionate—Tenderness—Gemcitabine—lung cancer	0.000864	0.00773	CcSEcCtD
Clobetasol propionate—Alopecia—Pemetrexed—lung cancer	0.000811	0.00726	CcSEcCtD
Clobetasol propionate—Alopecia—Gefitinib—lung cancer	0.000806	0.00721	CcSEcCtD
Clobetasol propionate—Tenderness—Cisplatin—lung cancer	0.000805	0.00721	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—lung cancer	0.000801	0.00717	CcSEcCtD
Clobetasol propionate—Erythema—Pemetrexed—lung cancer	0.000799	0.00715	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—lung cancer	0.000786	0.00703	CcSEcCtD
Clobetasol propionate—Tingling sensation—Paclitaxel—lung cancer	0.000785	0.00703	CcSEcCtD
Clobetasol propionate—Eye irritation—Paclitaxel—lung cancer	0.000739	0.00662	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Crizotinib—lung cancer	0.000739	0.00661	CcSEcCtD
Clobetasol propionate—Tenderness—Paclitaxel—lung cancer	0.000724	0.00648	CcSEcCtD
Clobetasol propionate—Dry skin—Erlotinib—lung cancer	0.000722	0.00646	CcSEcCtD
Clobetasol propionate—Infection—Crizotinib—lung cancer	0.000709	0.00634	CcSEcCtD
Clobetasol propionate—Skin disorder—Crizotinib—lung cancer	0.000693	0.0062	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Pemetrexed—lung cancer	0.000675	0.00605	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Gefitinib—lung cancer	0.000671	0.00601	CcSEcCtD
Clobetasol propionate—Alopecia—Teniposide—lung cancer	0.000657	0.00588	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Methotrexate—lung cancer	0.000648	0.0058	CcSEcCtD
Clobetasol propionate—Infection—Pemetrexed—lung cancer	0.000648	0.0058	CcSEcCtD
Clobetasol propionate—Infection—Gefitinib—lung cancer	0.000644	0.00576	CcSEcCtD
Clobetasol propionate—Paraesthesia—Crizotinib—lung cancer	0.000641	0.00573	CcSEcCtD
Clobetasol propionate—Skin disorder—Pemetrexed—lung cancer	0.000633	0.00567	CcSEcCtD
Clobetasol propionate—Skin disorder—Gefitinib—lung cancer	0.000629	0.00563	CcSEcCtD
Clobetasol propionate—Eruption—Methotrexate—lung cancer	0.000627	0.00561	CcSEcCtD
Clobetasol propionate—Eye irritation—Docetaxel—lung cancer	0.000627	0.00561	CcSEcCtD
Clobetasol propionate—Folliculitis—Methotrexate—lung cancer	0.000614	0.00549	CcSEcCtD
Clobetasol propionate—Psoriasis—Methotrexate—lung cancer	0.000614	0.00549	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vinblastine—lung cancer	0.000564	0.00505	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—lung cancer	0.000561	0.00502	CcSEcCtD
Clobetasol propionate—Pain—Pemetrexed—lung cancer	0.000558	0.00499	CcSEcCtD
Clobetasol propionate—Pain—Gefitinib—lung cancer	0.000554	0.00496	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Topotecan—lung cancer	0.000548	0.00491	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—lung cancer	0.000543	0.00486	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Erlotinib—lung cancer	0.000536	0.00479	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—lung cancer	0.000531	0.00475	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—lung cancer	0.000531	0.00475	CcSEcCtD
Clobetasol propionate—Infection—Teniposide—lung cancer	0.000525	0.0047	CcSEcCtD
Clobetasol propionate—Dexamethasone—ANXA1—lung cancer	0.00052	0.125	CrCbGaD
Clobetasol propionate—Alopecia—Vinblastine—lung cancer	0.000501	0.00449	CcSEcCtD
Clobetasol propionate—Alopecia—Topotecan—lung cancer	0.000487	0.00436	CcSEcCtD
Clobetasol propionate—Alopecia—Erlotinib—lung cancer	0.000482	0.00431	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Pemetrexed—lung cancer	0.00048	0.0043	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Gefitinib—lung cancer	0.000477	0.00427	CcSEcCtD
Clobetasol propionate—Erythema—Erlotinib—lung cancer	0.000475	0.00425	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vinorelbine—lung cancer	0.000469	0.0042	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vinorelbine—lung cancer	0.000463	0.00415	CcSEcCtD
Clobetasol propionate—Pruritus—Pemetrexed—lung cancer	0.000461	0.00413	CcSEcCtD
Clobetasol propionate—Pruritus—Gefitinib—lung cancer	0.000458	0.0041	CcSEcCtD
Clobetasol propionate—Pain in extremity—Paclitaxel—lung cancer	0.000458	0.0041	CcSEcCtD
Clobetasol propionate—Rash—Crizotinib—lung cancer	0.00045	0.00403	CcSEcCtD
Clobetasol propionate—Dermatitis—Crizotinib—lung cancer	0.000449	0.00402	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Gemcitabine—lung cancer	0.000427	0.00382	CcSEcCtD
Clobetasol propionate—Dry skin—Paclitaxel—lung cancer	0.00042	0.00376	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—lung cancer	0.000419	0.00375	CcSEcCtD
Clobetasol propionate—Alopecia—Vinorelbine—lung cancer	0.000416	0.00373	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—lung cancer	0.000412	0.00369	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—lung cancer	0.000412	0.00369	CcSEcCtD
Clobetasol propionate—Rash—Pemetrexed—lung cancer	0.000411	0.00368	CcSEcCtD
Clobetasol propionate—Dermatitis—Pemetrexed—lung cancer	0.000411	0.00368	CcSEcCtD
Clobetasol propionate—Erythema—Vinorelbine—lung cancer	0.00041	0.00367	CcSEcCtD
Clobetasol propionate—Rash—Gefitinib—lung cancer	0.000408	0.00366	CcSEcCtD
Clobetasol propionate—Dermatitis—Gefitinib—lung cancer	0.000408	0.00365	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000405	0.00363	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.000401	0.00359	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Teniposide—lung cancer	0.000389	0.00348	CcSEcCtD
Clobetasol propionate—Infection—Topotecan—lung cancer	0.000389	0.00348	CcSEcCtD
Clobetasol propionate—Pain in extremity—Docetaxel—lung cancer	0.000388	0.00348	CcSEcCtD
Clobetasol propionate—Infection—Erlotinib—lung cancer	0.000385	0.00344	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Irinotecan—lung cancer	0.000382	0.00342	CcSEcCtD
Clobetasol propionate—Skin disorder—Topotecan—lung cancer	0.00038	0.0034	CcSEcCtD
Clobetasol propionate—Skin disorder—Erlotinib—lung cancer	0.000376	0.00337	CcSEcCtD
Clobetasol propionate—Pruritus—Teniposide—lung cancer	0.000374	0.00334	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Gemcitabine—lung cancer	0.000373	0.00334	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Gemcitabine—lung cancer	0.000372	0.00333	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vinblastine—lung cancer	0.000362	0.00324	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Paclitaxel—lung cancer	0.000357	0.0032	CcSEcCtD
Clobetasol propionate—Dry skin—Docetaxel—lung cancer	0.000356	0.00319	CcSEcCtD
Clobetasol propionate—Paraesthesia—Topotecan—lung cancer	0.000351	0.00315	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000347	0.0031	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Cisplatin—lung cancer	0.000347	0.0031	CcSEcCtD
Clobetasol propionate—Pain—Vinblastine—lung cancer	0.000345	0.00308	CcSEcCtD
Clobetasol propionate—Alopecia—Irinotecan—lung cancer	0.000343	0.00307	CcSEcCtD
Clobetasol propionate—Pain—Topotecan—lung cancer	0.000335	0.003	CcSEcCtD
Clobetasol propionate—Alopecia—Gemcitabine—lung cancer	0.000335	0.00299	CcSEcCtD
Clobetasol propionate—Rash—Teniposide—lung cancer	0.000333	0.00298	CcSEcCtD
Clobetasol propionate—Dermatitis—Teniposide—lung cancer	0.000333	0.00298	CcSEcCtD
Clobetasol propionate—Infection—Vinorelbine—lung cancer	0.000333	0.00298	CcSEcCtD
Clobetasol propionate—Pain—Erlotinib—lung cancer	0.000331	0.00296	CcSEcCtD
Clobetasol propionate—Headache—Teniposide—lung cancer	0.000331	0.00296	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—lung cancer	0.00033	0.00295	CcSEcCtD
Clobetasol propionate—Erythema—Gemcitabine—lung cancer	0.00033	0.00295	CcSEcCtD
Clobetasol propionate—Skin disorder—Vinorelbine—lung cancer	0.000325	0.00291	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—lung cancer	0.000322	0.00288	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Paclitaxel—lung cancer	0.000315	0.00282	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Paclitaxel—lung cancer	0.000312	0.00279	CcSEcCtD
Clobetasol propionate—Alopecia—Cisplatin—lung cancer	0.000312	0.00279	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Paclitaxel—lung cancer	0.000312	0.00279	CcSEcCtD
Clobetasol propionate—Erythema—Cisplatin—lung cancer	0.000307	0.00275	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vinorelbine—lung cancer	0.000301	0.00269	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vinblastine—lung cancer	0.000297	0.00266	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Topotecan—lung cancer	0.000288	0.00258	CcSEcCtD
Clobetasol propionate—Pain—Vinorelbine—lung cancer	0.000286	0.00256	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—lung cancer	0.000286	0.00256	CcSEcCtD
Clobetasol propionate—Prednisolone—CYP2A6—lung cancer	0.00028	0.0675	CrCbGaD
Clobetasol propionate—Alopecia—Paclitaxel—lung cancer	0.00028	0.00251	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000279	0.00249	CcSEcCtD
Clobetasol propionate—Pruritus—Topotecan—lung cancer	0.000277	0.00248	CcSEcCtD
Clobetasol propionate—Erythema—Paclitaxel—lung cancer	0.000276	0.00247	CcSEcCtD
Clobetasol propionate—Infection—Irinotecan—lung cancer	0.000274	0.00246	CcSEcCtD
Clobetasol propionate—Pruritus—Erlotinib—lung cancer	0.000274	0.00245	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—lung cancer	0.000271	0.00243	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Docetaxel—lung cancer	0.000267	0.00239	CcSEcCtD
Clobetasol propionate—Infection—Gemcitabine—lung cancer	0.000267	0.00239	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Docetaxel—lung cancer	0.000265	0.00237	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Docetaxel—lung cancer	0.000264	0.00236	CcSEcCtD
Clobetasol propionate—Skin disorder—Gemcitabine—lung cancer	0.000261	0.00234	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00026	0.00232	CcSEcCtD
Clobetasol propionate—Headache—Vinblastine—lung cancer	0.000252	0.00226	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—lung cancer	0.000251	0.00225	CcSEcCtD
Clobetasol propionate—Infection—Cisplatin—lung cancer	0.000249	0.00223	CcSEcCtD
Clobetasol propionate—Paraesthesia—Irinotecan—lung cancer	0.000248	0.00222	CcSEcCtD
Clobetasol propionate—Rash—Topotecan—lung cancer	0.000247	0.00221	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vinorelbine—lung cancer	0.000247	0.00221	CcSEcCtD
Clobetasol propionate—Dermatitis—Topotecan—lung cancer	0.000247	0.00221	CcSEcCtD
Clobetasol propionate—Headache—Topotecan—lung cancer	0.000245	0.00219	CcSEcCtD
Clobetasol propionate—Rash—Erlotinib—lung cancer	0.000244	0.00219	CcSEcCtD
Clobetasol propionate—Dermatitis—Erlotinib—lung cancer	0.000244	0.00218	CcSEcCtD
Clobetasol propionate—Skin disorder—Cisplatin—lung cancer	0.000244	0.00218	CcSEcCtD
Clobetasol propionate—Headache—Erlotinib—lung cancer	0.000243	0.00217	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—lung cancer	0.000242	0.00217	CcSEcCtD
Clobetasol propionate—Paraesthesia—Gemcitabine—lung cancer	0.000242	0.00216	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000238	0.00213	CcSEcCtD
Clobetasol propionate—Alopecia—Docetaxel—lung cancer	0.000237	0.00213	CcSEcCtD
Clobetasol propionate—Pruritus—Vinorelbine—lung cancer	0.000237	0.00212	CcSEcCtD
Clobetasol propionate—Pain—Irinotecan—lung cancer	0.000236	0.00211	CcSEcCtD
Clobetasol propionate—Erythema—Docetaxel—lung cancer	0.000234	0.00209	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000233	0.00209	CcSEcCtD
Clobetasol propionate—Pain—Gemcitabine—lung cancer	0.00023	0.00206	CcSEcCtD
Clobetasol propionate—Infection—Etoposide—lung cancer	0.000228	0.00204	CcSEcCtD
Clobetasol propionate—Paraesthesia—Cisplatin—lung cancer	0.000225	0.00202	CcSEcCtD
Clobetasol propionate—Infection—Paclitaxel—lung cancer	0.000224	0.002	CcSEcCtD
Clobetasol propionate—Skin disorder—Etoposide—lung cancer	0.000223	0.002	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—lung cancer	0.000222	0.00199	CcSEcCtD
Clobetasol propionate—Skin disorder—Paclitaxel—lung cancer	0.000219	0.00196	CcSEcCtD
Clobetasol propionate—Pain—Cisplatin—lung cancer	0.000214	0.00192	CcSEcCtD
Clobetasol propionate—Rash—Vinorelbine—lung cancer	0.000211	0.00189	CcSEcCtD
Clobetasol propionate—Dermatitis—Vinorelbine—lung cancer	0.000211	0.00189	CcSEcCtD
Clobetasol propionate—Headache—Vinorelbine—lung cancer	0.00021	0.00188	CcSEcCtD
Clobetasol propionate—Paraesthesia—Etoposide—lung cancer	0.000206	0.00185	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Irinotecan—lung cancer	0.000203	0.00182	CcSEcCtD
Clobetasol propionate—Paraesthesia—Paclitaxel—lung cancer	0.000202	0.00181	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000198	0.00177	CcSEcCtD
Clobetasol propionate—Pain—Etoposide—lung cancer	0.000196	0.00176	CcSEcCtD
Clobetasol propionate—Pain—Paclitaxel—lung cancer	0.000193	0.00172	CcSEcCtD
Clobetasol propionate—Pruritus—Gemcitabine—lung cancer	0.00019	0.0017	CcSEcCtD
Clobetasol propionate—Infection—Docetaxel—lung cancer	0.00019	0.0017	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—lung cancer	0.000189	0.00169	CcSEcCtD
Clobetasol propionate—Fluticasone furoate—ABCB1—lung cancer	0.000186	0.0447	CrCbGaD
Clobetasol propionate—Skin disorder—Docetaxel—lung cancer	0.000185	0.00166	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Cisplatin—lung cancer	0.000185	0.00165	CcSEcCtD
Clobetasol propionate—Rash—Irinotecan—lung cancer	0.000174	0.00156	CcSEcCtD
Clobetasol propionate—Dermatitis—Irinotecan—lung cancer	0.000174	0.00156	CcSEcCtD
Clobetasol propionate—Headache—Irinotecan—lung cancer	0.000173	0.00155	CcSEcCtD
Clobetasol propionate—Paraesthesia—Docetaxel—lung cancer	0.000171	0.00153	CcSEcCtD
Clobetasol propionate—Alopecia—Methotrexate—lung cancer	0.000171	0.00153	CcSEcCtD
Clobetasol propionate—Rash—Gemcitabine—lung cancer	0.00017	0.00152	CcSEcCtD
Clobetasol propionate—Dermatitis—Gemcitabine—lung cancer	0.000169	0.00152	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—lung cancer	0.000169	0.00151	CcSEcCtD
Clobetasol propionate—Erythema—Methotrexate—lung cancer	0.000169	0.00151	CcSEcCtD
Clobetasol propionate—Headache—Gemcitabine—lung cancer	0.000169	0.00151	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—lung cancer	0.000167	0.00149	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Paclitaxel—lung cancer	0.000166	0.00149	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—lung cancer	0.000165	0.00148	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—lung cancer	0.000165	0.00147	CcSEcCtD
Clobetasol propionate—Pain—Docetaxel—lung cancer	0.000163	0.00146	CcSEcCtD
Clobetasol propionate—Pruritus—Etoposide—lung cancer	0.000163	0.00145	CcSEcCtD
Clobetasol propionate—Dexamethasone—CYP2A6—lung cancer	0.00016	0.0385	CrCbGaD
Clobetasol propionate—Pruritus—Paclitaxel—lung cancer	0.000159	0.00143	CcSEcCtD
Clobetasol propionate—Rash—Cisplatin—lung cancer	0.000158	0.00141	CcSEcCtD
Clobetasol propionate—Dermatitis—Cisplatin—lung cancer	0.000158	0.00141	CcSEcCtD
Clobetasol propionate—Alopecia—Doxorubicin—lung cancer	0.000148	0.00133	CcSEcCtD
Clobetasol propionate—Methylprednisolone—ABCB1—lung cancer	0.000148	0.0356	CrCbGaD
Clobetasol propionate—Triamcinolone—PTGS2—lung cancer	0.000147	0.0353	CrCbGaD
Clobetasol propionate—Erythema—Doxorubicin—lung cancer	0.000146	0.00131	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—lung cancer	0.000145	0.0013	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—lung cancer	0.000145	0.0013	CcSEcCtD
Clobetasol propionate—Headache—Etoposide—lung cancer	0.000144	0.00129	CcSEcCtD
Clobetasol propionate—Dexamethasone—ABCG2—lung cancer	0.000143	0.0344	CrCbGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000143	0.00128	CcSEcCtD
Clobetasol propionate—Rash—Paclitaxel—lung cancer	0.000142	0.00127	CcSEcCtD
Clobetasol propionate—Dermatitis—Paclitaxel—lung cancer	0.000142	0.00127	CcSEcCtD
Clobetasol propionate—Headache—Paclitaxel—lung cancer	0.000141	0.00126	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Docetaxel—lung cancer	0.000141	0.00126	CcSEcCtD
Clobetasol propionate—Infection—Methotrexate—lung cancer	0.000137	0.00122	CcSEcCtD
Clobetasol propionate—Pruritus—Docetaxel—lung cancer	0.000135	0.00121	CcSEcCtD
Clobetasol propionate—Skin disorder—Methotrexate—lung cancer	0.000134	0.0012	CcSEcCtD
Clobetasol propionate—Paraesthesia—Methotrexate—lung cancer	0.000124	0.00111	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000123	0.0011	CcSEcCtD
Clobetasol propionate—Rash—Docetaxel—lung cancer	0.00012	0.00108	CcSEcCtD
Clobetasol propionate—Dermatitis—Docetaxel—lung cancer	0.00012	0.00108	CcSEcCtD
Clobetasol propionate—Betamethasone—PTGS2—lung cancer	0.00012	0.0289	CrCbGaD
Clobetasol propionate—Headache—Docetaxel—lung cancer	0.00012	0.00107	CcSEcCtD
Clobetasol propionate—Prednisone—ALB—lung cancer	0.000119	0.0286	CrCbGaD
Clobetasol propionate—Infection—Doxorubicin—lung cancer	0.000118	0.00106	CcSEcCtD
Clobetasol propionate—Pain—Methotrexate—lung cancer	0.000118	0.00105	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—lung cancer	0.000116	0.00104	CcSEcCtD
Clobetasol propionate—Dexamethasone—CYP2E1—lung cancer	0.000113	0.0273	CrCbGaD
Clobetasol propionate—Prednisone—ABCB1—lung cancer	0.000113	0.0272	CrCbGaD
Clobetasol propionate—Dexamethasone—CYP1A1—lung cancer	0.000112	0.0269	CrCbGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—lung cancer	0.000107	0.000957	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	0.000106	0.00129	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000106	0.00128	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000105	0.00127	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—lung cancer	0.000105	0.00127	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000104	0.00127	CbGpPWpGaD
Clobetasol propionate—Prednisolone—ABCB1—lung cancer	0.000104	0.0251	CrCbGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RB1—lung cancer	0.000104	0.00127	CbGpPWpGaD
Clobetasol propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000104	0.00127	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000103	0.00126	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—AKR1C1—lung cancer	0.000102	0.00124	CbGpPWpGaD
Clobetasol propionate—Betamethasone—ABCB1—lung cancer	0.000102	0.0246	CrCbGaD
Clobetasol propionate—Pain—Doxorubicin—lung cancer	0.000102	0.000912	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000102	0.00124	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Methotrexate—lung cancer	0.000101	0.000907	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—UGT1A1—lung cancer	0.000101	0.00122	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.0001	0.00122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—lung cancer	9.99e-05	0.00121	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—UGT1A1—lung cancer	9.93e-05	0.00121	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	9.91e-05	0.0012	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTP1—lung cancer	9.84e-05	0.0012	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—lung cancer	9.74e-05	0.00118	CbGpPWpGaD
Clobetasol propionate—Pruritus—Methotrexate—lung cancer	9.73e-05	0.000871	CcSEcCtD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—APOA1—lung cancer	9.65e-05	0.00117	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	9.52e-05	0.00116	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—lung cancer	9.52e-05	0.00116	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—lung cancer	9.44e-05	0.00115	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	9.44e-05	0.00115	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	9.37e-05	0.00114	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	9.21e-05	0.00112	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	9.2e-05	0.00112	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	9.18e-05	0.00112	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—KHSRP—lung cancer	9.17e-05	0.00112	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	9.16e-05	0.00111	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTM1—lung cancer	9.04e-05	0.0011	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTP1—lung cancer	9.03e-05	0.0011	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—lung cancer	9e-05	0.00109	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTP1—lung cancer	8.91e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	8.89e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	8.86e-05	0.00108	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—lung cancer	8.78e-05	0.000786	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	8.68e-05	0.00106	CbGpPWpGaD
Clobetasol propionate—Rash—Methotrexate—lung cancer	8.68e-05	0.000776	CcSEcCtD
Clobetasol propionate—Dermatitis—Methotrexate—lung cancer	8.67e-05	0.000776	CcSEcCtD
Clobetasol propionate—Headache—Methotrexate—lung cancer	8.62e-05	0.000771	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	8.57e-05	0.00104	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—HPGDS—lung cancer	8.56e-05	0.00104	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—lung cancer	8.5e-05	0.00103	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—lung cancer	8.43e-05	0.000754	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTT1—lung cancer	8.31e-05	0.00101	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTM1—lung cancer	8.3e-05	0.00101	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP2A6—lung cancer	8.21e-05	0.000998	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GCLC—lung cancer	8.21e-05	0.000998	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTM1—lung cancer	8.18e-05	0.000995	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—CREBBP—lung cancer	8.17e-05	0.000993	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—EIF2B5—lung cancer	8.02e-05	0.000975	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	8.01e-05	0.000975	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—lung cancer	7.99e-05	0.000972	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	7.94e-05	0.000966	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL6—lung cancer	7.78e-05	0.000946	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	7.72e-05	0.000939	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	7.71e-05	0.000937	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—lung cancer	7.65e-05	0.00093	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CDKN1A—lung cancer	7.61e-05	0.000925	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—lung cancer	7.51e-05	0.000672	CcSEcCtD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	7.51e-05	0.000913	CbGpPWpGaD
Clobetasol propionate—Dermatitis—Doxorubicin—lung cancer	7.5e-05	0.000672	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	7.49e-05	0.000911	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	7.49e-05	0.00091	CbGpPWpGaD
Clobetasol propionate—Headache—Doxorubicin—lung cancer	7.46e-05	0.000668	CcSEcCtD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	7.3e-05	0.000888	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	7.29e-05	0.000887	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—DICER1—lung cancer	7.25e-05	0.000881	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	7.13e-05	0.000866	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	7.13e-05	0.000866	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.04e-05	0.000856	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—PTGS2—lung cancer	6.99e-05	0.0168	CrCbGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP2E1—lung cancer	6.98e-05	0.000849	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	6.98e-05	0.000849	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	6.93e-05	0.000843	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	6.93e-05	0.000843	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AZIN2—lung cancer	6.92e-05	0.000841	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—COL4A3BP—lung cancer	6.92e-05	0.000841	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	6.89e-05	0.000837	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	6.85e-05	0.000833	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—STAT3—lung cancer	6.79e-05	0.000825	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	6.78e-05	0.000825	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	6.75e-05	0.000821	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	6.67e-05	0.000811	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—lung cancer	6.51e-05	0.000791	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.45e-05	0.000785	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	6.38e-05	0.000776	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	6.32e-05	0.000769	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SKI—lung cancer	6.26e-05	0.000761	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	6.25e-05	0.000761	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.25e-05	0.00076	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	6.21e-05	0.000755	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	6.07e-05	0.000739	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	6.07e-05	0.000739	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—ABCB1—lung cancer	5.94e-05	0.0143	CrCbGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	5.92e-05	0.00072	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ATP5H—lung cancer	5.88e-05	0.000715	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—POMC—lung cancer	5.87e-05	0.000713	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	5.84e-05	0.00071	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTP1—lung cancer	5.76e-05	0.0007	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	5.74e-05	0.000698	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	5.68e-05	0.000691	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—EP300—lung cancer	5.56e-05	0.000677	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—lung cancer	5.51e-05	0.00067	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—lung cancer	5.44e-05	0.000662	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.41e-05	0.000657	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTM1—lung cancer	5.29e-05	0.000643	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PLBD1—lung cancer	5.24e-05	0.000638	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	5.22e-05	0.000635	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.16e-05	0.000627	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—RARB—lung cancer	5.02e-05	0.000611	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP1A1—lung cancer	5.02e-05	0.00061	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	4.95e-05	0.000602	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—NPPA—lung cancer	4.9e-05	0.000595	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	4.88e-05	0.000593	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HSD17B10—lung cancer	4.8e-05	0.000583	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—IL6—lung cancer	4.74e-05	0.000576	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CKB—lung cancer	4.46e-05	0.000542	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AZIN2—lung cancer	4.41e-05	0.000537	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—COL4A3BP—lung cancer	4.41e-05	0.000537	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—HSPB1—lung cancer	4.21e-05	0.000512	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CNDP2—lung cancer	4.19e-05	0.00051	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM2—lung cancer	4.19e-05	0.00051	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.11e-05	0.0005	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	4.1e-05	0.000498	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—MTMR3—lung cancer	4.08e-05	0.000496	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.98e-05	0.000484	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PGAM1—lung cancer	3.97e-05	0.000483	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	3.88e-05	0.000472	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP2A7—lung cancer	3.79e-05	0.000461	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	3.75e-05	0.000456	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ATP5H—lung cancer	3.75e-05	0.000456	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—POMC—lung cancer	3.74e-05	0.000455	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—NOTCH3—lung cancer	3.71e-05	0.000451	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SDC4—lung cancer	3.71e-05	0.000451	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—JUNB—lung cancer	3.51e-05	0.000427	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.45e-05	0.000419	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—RRM1—lung cancer	3.38e-05	0.000411	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA3—lung cancer	3.38e-05	0.000411	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PLBD1—lung cancer	3.34e-05	0.000407	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.29e-05	0.0004	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—B4GALT5—lung cancer	3.18e-05	0.000386	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA4—lung cancer	3.09e-05	0.000376	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HSD17B10—lung cancer	3.06e-05	0.000372	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA2—lung cancer	3.01e-05	0.000366	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTA1—lung cancer	2.91e-05	0.000353	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ABCC3—lung cancer	2.87e-05	0.000349	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CKB—lung cancer	2.84e-05	0.000346	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKR1C1—lung cancer	2.78e-05	0.000338	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—UGT1A1—lung cancer	2.7e-05	0.000329	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM2—lung cancer	2.67e-05	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CNDP2—lung cancer	2.67e-05	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GNG11—lung cancer	2.6e-05	0.000317	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—MTMR3—lung cancer	2.6e-05	0.000316	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.59e-05	0.000315	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ERCC2—lung cancer	2.55e-05	0.00031	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PGAM1—lung cancer	2.53e-05	0.000308	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALDOA—lung cancer	2.48e-05	0.000302	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP2A7—lung cancer	2.42e-05	0.000294	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NCOA3—lung cancer	2.41e-05	0.000293	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.37e-05	0.000288	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SDC4—lung cancer	2.37e-05	0.000288	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ADCY1—lung cancer	2.34e-05	0.000285	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ABCG2—lung cancer	2.34e-05	0.000285	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MYC—lung cancer	2.3e-05	0.00028	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HPGDS—lung cancer	2.3e-05	0.000279	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ENO2—lung cancer	2.3e-05	0.000279	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPP2R1B—lung cancer	2.28e-05	0.000278	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.25e-05	0.000274	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTT1—lung cancer	2.23e-05	0.000271	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GCLC—lung cancer	2.2e-05	0.000268	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP2A6—lung cancer	2.2e-05	0.000268	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.19e-05	0.000267	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—RRM1—lung cancer	2.15e-05	0.000262	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA3—lung cancer	2.15e-05	0.000262	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ENO1—lung cancer	2.09e-05	0.000254	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.08e-05	0.000253	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.05e-05	0.00025	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—B4GALT5—lung cancer	2.03e-05	0.000246	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA4—lung cancer	1.97e-05	0.00024	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.93e-05	0.000234	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA2—lung cancer	1.92e-05	0.000234	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP2E1—lung cancer	1.87e-05	0.000228	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CREBBP—lung cancer	1.87e-05	0.000227	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTA1—lung cancer	1.85e-05	0.000225	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NQO1—lung cancer	1.85e-05	0.000225	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ABCC3—lung cancer	1.83e-05	0.000223	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.81e-05	0.00022	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.8e-05	0.000218	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKR1C1—lung cancer	1.77e-05	0.000216	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—UGT1A1—lung cancer	1.72e-05	0.000209	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—STK11—lung cancer	1.67e-05	0.000203	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GNG11—lung cancer	1.66e-05	0.000202	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.65e-05	0.000201	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALDOA—lung cancer	1.58e-05	0.000192	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.57e-05	0.000191	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTP1—lung cancer	1.54e-05	0.000188	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NCOA3—lung cancer	1.54e-05	0.000187	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.51e-05	0.000183	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CAT—lung cancer	1.5e-05	0.000183	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.49e-05	0.000182	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ADCY1—lung cancer	1.49e-05	0.000182	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ABCG2—lung cancer	1.49e-05	0.000182	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HPGDS—lung cancer	1.46e-05	0.000178	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ENO2—lung cancer	1.46e-05	0.000178	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ABCB1—lung cancer	1.46e-05	0.000178	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.46e-05	0.000177	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.44e-05	0.000175	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TYMS—lung cancer	1.44e-05	0.000175	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTT1—lung cancer	1.42e-05	0.000173	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM1—lung cancer	1.42e-05	0.000173	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GCLC—lung cancer	1.4e-05	0.000171	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP2A6—lung cancer	1.4e-05	0.000171	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.4e-05	0.00017	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ERCC2—lung cancer	1.33e-05	0.000162	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ENO1—lung cancer	1.33e-05	0.000162	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.33e-05	0.000161	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.31e-05	0.000159	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP2E1—lung cancer	1.19e-05	0.000145	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NQO1—lung cancer	1.18e-05	0.000144	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.16e-05	0.000141	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—APOA1—lung cancer	1.15e-05	0.00014	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.15e-05	0.000139	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MAPK3—lung cancer	1.14e-05	0.000139	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MYC—lung cancer	1.11e-05	0.000135	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.11e-05	0.000134	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—STK11—lung cancer	1.06e-05	0.000129	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CG—lung cancer	1.05e-05	0.000128	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—POMC—lung cancer	1e-05	0.000122	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.99e-06	0.000121	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTP1—lung cancer	9.85e-06	0.00012	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CREBBP—lung cancer	9.77e-06	0.000119	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CAT—lung cancer	9.58e-06	0.000117	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.53e-06	0.000116	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ABCB1—lung cancer	9.32e-06	0.000113	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CD—lung cancer	9.26e-06	0.000113	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TYMS—lung cancer	9.15e-06	0.000111	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ALB—lung cancer	9.14e-06	0.000111	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM1—lung cancer	9.05e-06	0.00011	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP1A1—lung cancer	8.58e-06	0.000104	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ERCC2—lung cancer	8.51e-06	0.000103	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CB—lung cancer	8.07e-06	9.82e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTGS2—lung cancer	8e-06	9.73e-05	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—AKT1—lung cancer	7.69e-06	9.35e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—APOA1—lung cancer	7.36e-06	8.95e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.05e-06	8.57e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—lung cancer	6.98e-06	8.48e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CG—lung cancer	6.72e-06	8.17e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—EP300—lung cancer	6.65e-06	8.09e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—POMC—lung cancer	6.4e-06	7.78e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CREBBP—lung cancer	6.23e-06	7.57e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CD—lung cancer	5.91e-06	7.18e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ALB—lung cancer	5.83e-06	7.09e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CB—lung cancer	5.15e-06	6.26e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTGS2—lung cancer	5.1e-06	6.2e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PIK3CA—lung cancer	4.92e-06	5.99e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—lung cancer	4.45e-06	5.41e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—EP300—lung cancer	4.24e-06	5.16e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—AKT1—lung cancer	4.02e-06	4.89e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PIK3CA—lung cancer	3.14e-06	3.82e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—AKT1—lung cancer	2.56e-06	3.12e-05	CbGpPWpGaD
